GLOUCESTER 2020

Gloucestershire Health + Care NHS Foundation Trust

Trust HQ
Edward Jenner Court
1010 Pioneer Avenue
Brockworth
Gloucester
GL3 4AW

Direct Tel: 0300 421 8414
E-mail: freedomofinformation@ghc.nhs.uk
Website: www.ghc.nhs.uk

DATE: 06/08/2021

Sent via e-mail to:- Wendy Micklewright
<wmicklewright@yahoo.co.uk>

Dear Mrs Micklewright,

Freedom of Information Request – Ref: FOI 179-2122

Thank you for your recent Freedom of Information request. Please find our response below.

Please find out response for ECT
1. Please supply patient’s information ECT leaflet.	Please see attached as a separate PDF document.
2. Please supply patient ECT consent form.	Please see attached as a separate PDF document.
3. Please supply any ECT reports/investigations	These would contain patient identifiable information and therefore cannot be supplied.
4. How many ECT in 2020?	10 patients received ECT
5. What proportion of patients were men/women?	6 - Female 4 - Male
6. How old were they?	X2 at 54yrs old, 64yrs old, 65yrs old, 67yrs old, 68yrs old, 71yrs old, 73yrs old, 79yrs old and 85yrs old.
7. What proportion of patients were classified BAME?	None
8. How many were receiving ECT for the first time?	9
9. How many patients consented to ECT?	6
10. How many ECT complaints were investigated outside the NHS and CCG?	None - Not informed of any formal complaint.
11. How many patients died during or 1 month after ECT and what was the cause (whether or not ECT was considered the cause)?	None
12. How many patients died a six months after ECT and what was the cause (whether or not ECT was considered the cause)?	None
13. How many patients died by suicide within 6 months of receiving ECT (whether or not ECT was considered the cause)?	None
14. How many patients have suffered complications during and after ECT and what were those complications?	None
15. Have there been any formal complaints from patients/relatives about ECT?	No
16. If so, what was their concerns?	N/A
17. How many patients report memory loss/loss of	None
cognitive function?
18. What tests are used to assess memory loss/loss of cognitive function?	MoCA and CPRS
19. Have MRI or CT scans been used before and after ECT?	No
20. If so what was the conclusion?	N/A
21. How does the Trust plan to prevent ECT in the future?	Currently no plans in place.

Please find our response for SERIOUS INCIDENT
1. Please supply any serious incident reports/investigations	These would contain patient identifiable information and therefore cannot be supplied.
2. How many SERIOUS INCIDENT REPORTS in 2020?	41 (involving 46 patients because this includes the sexual health and wheelchair investigations)
3. What proportion of patients were men/women?	41% Male 57% Female, 2% Not known (26 female, 19 male, 1 not stated)
4. How old were they?	Range 20 – 96 years old
5. What proportion of patients were classified BAME?	0% (6 not stated, 40 white)
6. How many SERIOUS INCIDENT REPORTS were investigated outside the NHS and CCG?	None.
7. How many patients died during or 1 month after SERIOUS INCIDENT REPORTS and what was the cause (whether or not SERIOUS INCIDENT REPORTS was considered the cause)?	17 1 End-of-life and 16 suicides (tbc)
8. How many patients died within 6 months after SERIOUS INCIDENT REPORTS and what was the cause (whether or not SERIOUS INCIDENT REPORTS was considered the cause)?	Including the 17 above, 20 3 End-of-life and 17 suicides (tbc)
9. How many patients died by suicide within 6 months of receiving SERIOUS INCIDENT REPORTS (whether or not SERIOUS INCIDENT REPORTS was considered the cause)?	17 (tbc)
10. How many patients have suffered complications during and after SERIOUS INCIDENT REPORTS and what were those complications?	TBC
11. Have there been any formal complaints from patients/relatives about SERIOUS INCIDENT REPORTS? No	No
12. If so, what was their concerns?	N/A
13. How does the Trust plan to prevent SERIOUS INCIDENTS in the future?	We will implement the Trust’s developing Patient Safety Incident Response Plan (PSIRP). This is in response to the Patient Safety Incident Response Framework (PSIRF) which itself is published by NHS England following their development of the Patient Safety Strategy. These changes are currently being prepared for roll-out across the NHS estate nationwide by the National Patient Safety Team.

Please find our response for RESTRAINTS
1. Please supply any Restraints/investigations.	These would contain patient identifiable information and therefore cannot be supplied.
2. How many RESTRAINTS in 2020?	2179
3. What proportion of patients were men/women?	Men – 50.8% Women – 49.2%
4. How old were they?	Age under 12	0.3%
	12-17 years old	1.6%
	18-24 years old	13.8%
	25-34 years old	19.1%
	35-44 years old	20.1%
	45-54 years old	18.8%
	55-64 years old	11.9%
	65-74 years old	5.3%
	75 years or older	9.1%
5. What proportion of patients were classified BAME?	White - 88.4% BAME - 7.5% Unknown - 4.1%
6. How many RESTRAINTS were investigated outside the NHS and CCG	None known.
7. How many patients died during or 1 month after RESTRAINTS and what was the cause (whether or not RESTRAINTS was considered the cause)?	This information is unfortunately not available without accessing each patient’s clinical record.
8. How many patients died 6 months after RESTRAINTS and what was the cause (whether or not RESTRAINTS was considered the cause)?	This information is unfortunately not available without accessing each patient’s clinical record.
9. How many patients died by suicide within 6 months of receiving RESTRAINTS (whether or not RESTRAINTS was considered the cause)?	This information is unfortunately not available without accessing each patient’s clinical record.
10. How many patients have suffered complications during and after RESTRAINTS and what were those complications?	This information is unfortunately not available without accessing each patient’s clinical record.
11. Have there been any formal complaints from patients/relatives about RESTRAINTS?	None
12. If so, what was their concerns?	N/A
13. Are counts of forced injections available?	We record the number of intra-muscular (IM) rapid tranquilisations.
14. How does the Trust plan to reduce restraints in the future?	Reducing Restrictive Intervention Action Plans are currently under review and are due to be co-revised with Service Users as soon as relaxation of Covid-19 restrictions allow. We are taking part in a National Patient Safety Improvement Programme on Reducing Restrictive Practices, starting in August.

Please find our response for MEDICATION ERRORS
1. Please supply any MEDICATION ERRORS reports/investigations	These would contain patient identifiable information and therefore cannot be supplied.
2. How many MEDICATION ERRORS in 2020?	615
3. What proportion of patients were men/women?	Men - 49.7% Women - 50.1% Unknown - 0.2%
4. How old were they?	Age under 12	1.40%
	12-17 years old	1.40%
	18-24 years old	3.70%
	25-34 years old	5.50%
	35-44 years old	5.70%
	45-54 years old	9.60%
	55-64 years old	11.20%
	65-74 years old	16.20%
	75 years or older	45.30%
5. What proportion of patients were classified	White - 87.9%
BAME?	BAME - 4.6% Unknown - 7.5%
6. How many MEDICATION ERRORS were investigated outside the NHS and CCG?	None known.
7. How many patients died during or 1 month after MEDICATION ERRORS and what was the cause (whether or not MEDICATION ERRORS was considered the cause)?	This information is unfortunately not available without accessing each patient’s clinical record.
8. How many patients died within 6 months after MEDICATION ERRORS and what was the cause (whether or not MEDICATION ERRORS was considered the cause)?	This information is unfortunately not available without accessing each patient’s clinical record.
9. How many patients died by suicide within 6 months of receiving MEDICATION ERRORS (whether or not MEDICATION ERRORS was considered the cause)?	This information is unfortunately not available without accessing each patient’s clinical record.
10. How many patients have suffered complications during and after MEDICATION ERRORS and what were those complications?	This information is unfortunately not available without accessing each patient’s clinical record.
11. Have there been any formal complaints from patients/relatives about MEDICATION ERRORS?	Yes, one.
12. If so, what was their concerns?	Anti-psychotic medication causing gastrointestinal side effects.
13. How does the Trust plan to prevent MEDICATION ERRORS in the future?	All medication errors are reviewed as part of the Trust’s incident management process. Themes and trends are identified and training/resources made available to support colleagues to get medicines right. Individual training, support and supervision around managing medicines is available for colleagues. Learning from incidents is also shared across the Trust.

Should you have any queries in relation to our response in this letter, please do not hesitate to contact me. If you are unhappy with the response you have received in relation to your request and wish to ask us to review our response, you should write to:-

Louise Moss
Associate Director of Corporate Governance
Gloucestershire Health and Care NHS Foundation Trust
Edward Jenner Court
1010 Pioneer Avenue
Gloucester Business Park
Brockworth
GLOUCESTER GL3 4AW
Tel: 0300 421 8321
E-mail: louise.moss@ghc.nhs.uk

If you are not content with the outcome of any review, you may apply directly to the Information
Commissioner’s Office (ICO) for further advice/guidance. Generally, the ICO will not consider your case unless you have exhausted your enquiries with the Trust which should include considering the use of the Trust’s formal complaints procedure. The ICO can be contacted at: The Information Commissioner’s Office, Wycliffe House, Water Lane, Wilmslow, Cheshire SK9 5AF.

Yours sincerely,

Freedom of Information Officer
On behalf of Gloucestershire Health & Care NHS Foundation Trust

Copyright & Reuse of Public Sector Information

The information and material that is routinely published is subject to Gloucestershire Health & Care NHS Foundation Trust's
copyright unless otherwise indicated. Unless expressly indicated on the material to the contrary, it may be reproduced free of charge in any format or medium, provided it is reproduced accurately and not used in a misleading manner. Where any of the copyright items are being re -published or copied to others, you must identify the source of the material and acknowledge the copyright status. Permission to reproduce material does not extend to any material accessed through the Trust website that is the copyright of third parties. You must obtain authorisation to reproduce such material from the copyright holders concerned. For further guidance on a range of copyright issues, see the Office of Public Sector Information (OPSI) web site: www.opsi.gov.uk/advice/crow n -copyright/copyright-guidance/index.htm

Or write to: OPSI, 102 Petty France, London SW1H 9AJ.